What is MedEasyNow?
MedEasyNow is a digital health platform designed to make complex medical knowledge actionable, navigable, and usable across the healthcare ecosystem. Its mission is simple but ambitious: transform medical complexity into structured intelligence that supports better decisions—by clinicians, institutions, researchers, and innovators.
At the heart of MedEasyNow lies the Global Cancer Index (GCI).
The Global Cancer Index is a curated, evidence-based framework that organizes oncology knowledge around diseases, biomarkers, therapies, and clinical outcomes. Instead of treating scientific literature as an unstructured archive, GCI classifies high-impact studies using consistent clinical KPIs, levels of evidence, disease context, and therapeutic relevance. This allows users to quickly understand what works, where, and why—without drowning in publications.
MedEasyNow acts as the operational layer that turns this structured knowledge into tools: interactive dashboards, clinical maps, evidence pathways, educational modules, and integration-ready datasets. Together, MedEasyNow and the Global Cancer Index form a scalable infrastructure that bridges research, clinical practice, and digital health innovation.
This is not a content platform and not a diagnostic tool. It is a medical intelligence system—designed to grow with new evidence, support institutional use, enable partnerships, and integrate with AI-driven healthcare solutions.
MedEasyNow doesn’t replace expertise.
It amplifies it, by making evidence visible, comparable, and usable at scale.
Call for Investors
Cancer research is advancing faster than our ability to make sense of it. Every year, tens of thousands of oncology studies are published, yet clinicians, institutions, and innovators still struggle to identify which evidence truly changes clinical practice. The problem is no longer a lack of data—it is the absence of structure.
The Global Cancer Index was created to solve this problem.
It is a curated, evidence-based intelligence layer that transforms fragmented oncology literature into structured, comparable, and decision-ready knowledge. Instead of reading hundreds of papers, users can immediately understand what works, for whom, in which disease context, and with what level of evidence.
This platform is not designed for patients alone, nor only for researchers. It is built for oncologists, healthcare institutions, biotech companies, and digital health ecosystems that need reliable, interpretable evidence to guide strategy, clinical pathways, and innovation.
What makes the Global Cancer Index unique is its methodology: each study is classified using consistent clinical KPIs, disease context, biomarkers, and therapeutic impact—creating a living map of oncology progress.
From this core, multiple revenue and impact layers emerge: clinical decision support tools, institutional subscriptions, data licensing, educational platforms, and integration with AI-driven healthcare systems.
We are not building another database.
We are building the reference framework for understanding cancer in the age of data abundance.
This is an infrastructure investment—one that scales with every new discovery.
We are building the intelligence layer that turns oncology data into structured, actionable knowledge. MedEasyNow, powered by the Global Cancer Index, addresses one of healthcare’s biggest gaps: making evidence usable at scale. We are opening a limited investment round to accelerate platform growth and strategic partnerships. We invite forward-thinking investors to join us.
The Global Cancer Index
Turning Cancer Evidence into Public Value
The Global Cancer Index (GCI) is an independent, evidence-based initiative designed to structure, connect, and make high-quality oncology evidence usable as a shared public resource.
Rather than producing new clinical research, GCI focuses on organizing existing, peer-reviewed evidence into a coherent and transparent framework that supports clinicians, researchers, institutions, and policy stakeholders.
The Problem
Cancer knowledge is expanding rapidly, yet it remains fragmented across publications, specialties, and disease silos. Evidence is often organized by organ rather than by shared biological mechanisms, making it difficult to compare therapies, identify patterns, or translate validated knowledge into accessible and reusable structures.
This fragmentation limits informed decision-making, policy planning, and patient understanding.
The GCI Approach
GCI addresses this gap by creating a functional cancer evidence index built on three core principles.
First, evidence-first curation: only high-quality clinical trials, landmark studies, and recognized consensus frameworks are included, each curated using a standardized and transparent data model.
Second, a biology-driven perspective: evidence is indexed by biomarkers, mechanisms of action, and therapeutic strategies, enabling cross-tumor and tumor-agnostic analysis.
Third, actionable transparency: each entry explicitly links evidence to clinical context, level of validation, guideline relevance, and known limitations or sequencing considerations.
Current Status
The current minimum viable product includes more than sixty curated landmark oncology publications, spanning phase III trials, tumor-agnostic approvals, and foundational methodological frameworks.
A structured data model captures tumor type, biomarker, intervention, evidence level, and guideline impact. A live interactive dashboard enables real-time exploration and filtering of the evidence base.
This demonstrates an operational system rather than a conceptual proposal.
Who GCI Serves
GCI is designed to support public institutions and policy bodies seeking transparent evidence frameworks aligned with cancer missions and health data strategies.
It serves academic and research organizations by enabling comparative analysis, education, and strategic research planning.
It supports patient advocacy organizations and non-profits by improving access to understandable, validated cancer knowledge.
It also provides a neutral evidence layer for healthcare innovation programs developing responsible digital health and AI tools.
What GCI Is Not
GCI is not a diagnostic tool, not a clinical decision-making system, and not a replacement for medical judgment.
It is an evidence infrastructure intended to support understanding, transparency, and informed dialogue.
Collaboration and Funding Context
GCI is designed to grow through institutional partnerships, public and European funding frameworks, and non-profit and research collaborations.
Its guiding principle is public value creation grounded in scientific integrity and long-term sustainability.
MedEasyNow was created to bridge this gap
Our vision is both simple and ambitious:
to make medicine more understandable, more transparent, and above all more human.
Not as a system defined only by complexity, codes and protocols,
but as a shared space where individuals, professionals, researchers and institutions can contribute to collective progress — in a culture built on dignity, ethics, and mutual responsibility.
We believe that every health encounter — a visit, an examination, a treatment — represents far more than a clinical act.
It is a moment rich with meaning, one that holds the potential to benefit both the person involved and the wider community.
MedEasyNow embodies a new European pact
A pact grounded in transparency, dignity, shared responsibility and fair access to knowledge.
A pact that respects the value of each person and recognises the social value of health.
We are only at the beginning of this journey.
But we believe that together we can build a model that truly makes medicine easier — not only in name, but in essence.
A medicine that is clearer, kinder, and more capable of listening and giving back.
A medicine that sees each individual not just as a patient, but as a protagonist in a cultural transformation that concerns us all.
MedEasyNow as a bridge
A bridge between those who care for others and those who receive care.
A bridge between the knowledge generated in daily clinical practice and the innovations that can transform public health.
A bridge between European institutions shaping the future of healthcare and the citizens who live that future every day.
In our vision, the future of health is not defined by isolated technologies,
but by relationships — solid, trustworthy, transparent relationships.
Relationships in which each person knows that their contribution, protected and respected, helps generate value for society as a whole.
Our commitment is to build a cultural infrastructure before a technological one —
a context in which health is not a labyrinth but a clear pathway;
not a cryptic language but a pact of trust;
not a collection of scattered data but a coherent narrative in which every story contributes to the wellbeing of all.
About Us
For partnership requests, EU project collaboration or further information, please contact:
KRONEMED SRL – MedEasyNow.com – Global Cancer Index
Email: info@kronemed.com
Website: www.MedEasyNow.com www.kronemed.com
Country: Italy
Making Medicine Simple, Transparent, and Human Again
Medicine is evolving faster than ever — powered by technology, data, and global collaboration. Yet for most people, healthcare remains complex, fragmented, and difficult to understand.
At MedEasyNow.com, we believe that medicine should be easy — easy to access, easy to understand, and easy to trust.
Our mission is to bridge the gap between innovation and comprehension, turning medical complexity into clear knowledge, and advanced data systems into tools that empower both professionals and citizens.
A New Model of Digital Health Understanding
MedEasyNow brings together researchers, clinicians, technologists, and communicators to develop digital solutions that simplify healthcare — from understanding a lab result to tracking an entire therapeutic pathway.
Our initiatives combine:
-
Transparency: clear explanations of how medicine works and how data are managed.
-
Technology: blockchain, AI, and data integration tools that make health information verifiable and secure.
-
Trust: an ethical approach that protects privacy and promotes shared knowledge.
Beyond Information — Toward Real Health Empowerment
This platform is not just about providing information; it’s about creating understanding.
Through visual tools, interactive calculators, and new digital prototypes — such as the Blockchain Patient Journey and the Digital Health Passport — MedEasyNow helps transform raw medical data into actionable, human-centered insights.
We aim to build an ecosystem where:
-
Patients can follow their health journey transparently.
-
Researchers can access anonymized real-world data.
-
Institutions can collaborate on secure, interoperable systems for preventive and personalized care.
Our Philosophy: Ethics, Education, Innovation
Medicine today is data-driven — but data alone are not enough.
They must be accurate, ethically handled, and communicated with clarity.
That’s why every MedEasyNow project begins with the same question:
How can we make this simpler, clearer, and more useful for everyone?
From digital literacy initiatives to blockchain-based data validation, MedEasyNow acts as a laboratory of ideas for a future where innovation and understanding coexist.
Join the movement
We invite hospitals, laboratories, research institutions, and citizen groups to collaborate in developing a new model of accessible medicine, where every innovation contributes to better knowledge and better care.
MedEasyNow.com – Making medicine easy to understand, trust, and share.
Disclaimer & Scope of Information
MedEasyNow is an independent informational platform dedicated to organizing and presenting medical and scientific knowledge in a clear, structured, and accessible way. The content published on this website is based on publicly available scientific literature, clinical studies, and authoritative data sources.
The information provided on MedEasyNow is intended solely for educational and informational purposes. It does not constitute medical advice, diagnosis, or treatment, nor should it be used as a substitute for professional medical judgment. Medical decisions must always be made in consultation with qualified healthcare professionals, taking into account individual clinical circumstances.
While every effort is made to ensure accuracy, completeness, and transparency, medical knowledge is constantly evolving. MedEasyNow does not guarantee that the information presented is always up to date or applicable to every individual case.
References to therapies, diagnostic tests, biomarkers, or clinical outcomes are provided to illustrate scientific evidence and research developments, not to promote specific treatments or clinical choices. The inclusion of a study, therapy, or outcome does not imply endorsement or recommendation.
MedEasyNow does not engage in direct patient care, does not provide personalized medical guidance, and does not replace the role of healthcare professionals. Users of this website are encouraged to discuss any medical questions or decisions with their physicians or qualified medical providers.